Related references
Note: Only part of the references are listed.Effects of biological sex on the pathophysiology of the heart
Loubina Fazal et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Basis for Sex-Dependent Outcomes in Acute Coronary Syndrome
Mona Izadnegahdar et al.
CANADIAN JOURNAL OF CARDIOLOGY (2014)
Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events
Sanne A. E. Peters et al.
DIABETOLOGIA (2014)
Diabetic cardiomyopathy: Mechanisms and new treatment strategies targeting antioxidant signaling pathways
Karina Huynh et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Targeting the upregulation of reactive oxygen species subsequent to hyperglycemia prevents type 1 diabetic cardiomyopathy in mice
Karina Huynh et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Prevention by sulforaphane of diabetic cardiomyopathy is associated with up-regulation of Nrf2 expression and transcription activation
Yang Bai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2013)
Sexual dimorphism in rodent models of hypertension and atherosclerosis
Kristen J. Bubb et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Heart Disease and Stroke Statistics-2012 Update A Report From the American Heart Association
Veronique L. Roger et al.
CIRCULATION (2012)
Enhanced phosphoinositide 3-kinase(p110α) activity prevents diabetes-induced cardiomyopathy and superoxide generation in a mouse model of diabetes
R. H. Ritchie et al.
DIABETOLOGIA (2012)
Coenzyme Q10 attenuates diastolic dysfunction, cardiomyocyte hypertrophy and cardiac fibrosis in the db/db mouse model of type 2 diabetes
K. Huynh et al.
DIABETOLOGIA (2012)
Trends in death attributed to heart failure over the past two decades in Europe
Said Laribi et al.
EUROPEAN JOURNAL OF HEART FAILURE (2012)
Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
Eliane Q. Lin et al.
PLOS ONE (2012)
Genetic Deficiency of Plasminogen Activator Inhibitor-1 Promotes Cardiac Fibrosis in Aged Mice Involvement of Constitutive Transforming Growth Factor-β Signaling and Endothelial-to-Mesenchymal Transition
Asish K. Ghosh et al.
CIRCULATION (2010)
Cardiac-Specific IGF-1 Receptor Transgenic Expression Protects Against Cardiac Fibrosis and Diastolic Dysfunction in a Mouse Model of Diabetic Cardiomyopathy
Karina Huynh et al.
DIABETES (2010)
High-fructose diet elevates myocardial superoxide generation in mice in the absence of cardiac hypertrophy
Kimberley Mellor et al.
NUTRITION (2010)
Diabetic cardiomyopathy, causes and effects
Sihem Boudina et al.
REVIEWS IN ENDOCRINE & METABOLIC DISORDERS (2010)
Antibody blockade of c-fms suppresses the progression of inflammation and injury in early diabetic nephropathy in obese db/db mice
A. K. H. Lim et al.
DIABETOLOGIA (2009)
Diabetic Hypertensive Leptin Receptor-Deficient db/db Mice Develop Cardioregulatory Autonomic Dysfunction
Andrey C. da Costa Goncalves et al.
HYPERTENSION (2009)
Gene Remodeling in Type 2 Diabetic Cardiomyopathy and Its Phenotypic Rescue with SERCA2a
Ioannis Karakikes et al.
PLOS ONE (2009)
Mitochondrial energetics in the heart in obesity-related diabetes - Direct evidence for increased uncoupled respiration and activation of uncoupling proteins
Sihem Boudina et al.
DIABETES (2007)
Leptin signaling and obesity - Cardiovascular consequences
Ronghua Yang et al.
CIRCULATION RESEARCH (2007)
The antioxidant tempol inhibits cardiac hypertrophy in the insulin-resistant GLUT4-deficient mouse in vivo
R. H. Ritchie et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2007)
Magnetic resonance imaging of progressive cardiomyopathic changes in the db/db mouse
Patrick Yue et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes
Adrienne Laskowski et al.
CARDIOVASCULAR RESEARCH (2006)
Mechanical and metabolic rescue in a type II diabetes model of cardiomyopathy by targeted gene transfer
Susumu Sakata et al.
MOLECULAR THERAPY (2006)
High glucose alters cardiomyocyte contacts and inhibits myofibrillar formation
D Dyntar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy
J Asbun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats
LE Wold et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2005)
A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress
D Del Rio et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2005)
Molecular and cellular basis of cardiovascular gender differences
ME Mendelsohn et al.
SCIENCE (2005)
Diabetic cardiomyopathy: Evidence, mechanisms, and therapeutic implications
ZY Fang et al.
ENDOCRINE REVIEWS (2004)
Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk
I Juhan-Vague et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2003)
Adaptation and maladaptation of the heart in diabetes: Part I General concepts
H Taegtmeyer et al.
CIRCULATION (2002)
Changes in titin and collagen underlie diastolic stiffness diversity of cardiac muscle
YM Wu et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Impact of diabetes on cardiac structure and function - The strong heart study
RB Devereux et al.
CIRCULATION (2000)
Diminished expression of sarcoplasmic reticulum Ca2+-ATPase and ryanodine sensitive Ca2+ channel mRNA in streptozotocin-induced diabetic rat heart
Y Teshima et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2000)
Share Paper
